Cell-Free DNA (cfDNA) Testing Market - Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: C4C29CC883F8EN
Market Monitor Global

Abstracts

Cell-Free DNA are fragments of DNA which circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients and detect various chromosomal abnormalities in the fetus, to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation and infectious diseases.

This report contains market size and forecasts of Cell-Free DNA (cfDNA) Testing in Global, including the following market information:

Global Cell-Free DNA (cfDNA) Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cell-Free DNA (cfDNA) Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Donor-Derived Cell-Free DNA (DdcfDNA) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cell-Free DNA (cfDNA) Testing include Agilent Technology, Allenex, Biocept, Biodesix, CareDx, Guardant Health, Illumania, Invited and Natera, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell-Free DNA (cfDNA) Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cell-Free DNA (cfDNA) Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cell-Free DNA (cfDNA) Testing Market Segment Percentages, by Type, 2021 (%)

• Donor-Derived Cell-Free DNA (DdcfDNA)
• Circulating Cell-Free Tumor DNA (CtDNA)
• Cell-Free Fetal DNA (NIPT)

Global Cell-Free DNA (cfDNA) Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cell-Free DNA (cfDNA) Testing Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Ambulatory Surgical Centers
• Cancer Research Institutes

Global Cell-Free DNA (cfDNA) Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cell-Free DNA (cfDNA) Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cell-Free DNA (cfDNA) Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cell-Free DNA (cfDNA) Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Agilent Technology
• Allenex
• Biocept
• Biodesix
• CareDx
• Guardant Health
• Illumania
• Invited
• Natera
• Quest Diagnostics
• Roche Holdings
• Sequenom
• Trovagene

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cell-Free DNA (cfDNA) Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cell-Free DNA (cfDNA) Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CELL-FREE DNA (CFDNA) TESTING OVERALL MARKET SIZE

2.1 Global Cell-Free DNA (cfDNA) Testing Market Size: 2021 VS 2028
2.2 Global Cell-Free DNA (cfDNA) Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cell-Free DNA (cfDNA) Testing Players in Global Market
3.2 Top Global Cell-Free DNA (cfDNA) Testing Companies Ranked by Revenue
3.3 Global Cell-Free DNA (cfDNA) Testing Revenue by Companies
3.4 Top 3 and Top 5 Cell-Free DNA (cfDNA) Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cell-Free DNA (cfDNA) Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell-Free DNA (cfDNA) Testing Players in Global Market
  3.6.1 List of Global Tier 1 Cell-Free DNA (cfDNA) Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cell-Free DNA (cfDNA) Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cell-Free DNA (cfDNA) Testing Market Size Markets, 2021 & 2028
  4.1.2 Donor-Derived Cell-Free DNA (DdcfDNA)
  4.1.3 Circulating Cell-Free Tumor DNA (CtDNA)
  4.1.4 Cell-Free Fetal DNA (NIPT)
4.2 By Type - Global Cell-Free DNA (cfDNA) Testing Revenue & Forecasts
  4.2.1 By Type - Global Cell-Free DNA (cfDNA) Testing Revenue, 2017-2022
  4.2.2 By Type - Global Cell-Free DNA (cfDNA) Testing Revenue, 2023-2028
  4.2.3 By Type - Global Cell-Free DNA (cfDNA) Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cell-Free DNA (cfDNA) Testing Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Cancer Research Institutes
5.2 By Application - Global Cell-Free DNA (cfDNA) Testing Revenue & Forecasts
  5.2.1 By Application - Global Cell-Free DNA (cfDNA) Testing Revenue, 2017-2022
  5.2.2 By Application - Global Cell-Free DNA (cfDNA) Testing Revenue, 2023-2028
  5.2.3 By Application - Global Cell-Free DNA (cfDNA) Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cell-Free DNA (cfDNA) Testing Market Size, 2021 & 2028
6.2 By Region - Global Cell-Free DNA (cfDNA) Testing Revenue & Forecasts
  6.2.1 By Region - Global Cell-Free DNA (cfDNA) Testing Revenue, 2017-2022
  6.2.2 By Region - Global Cell-Free DNA (cfDNA) Testing Revenue, 2023-2028
  6.2.3 By Region - Global Cell-Free DNA (cfDNA) Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cell-Free DNA (cfDNA) Testing Revenue, 2017-2028
  6.3.2 US Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.3.3 Canada Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.3.4 Mexico Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cell-Free DNA (cfDNA) Testing Revenue, 2017-2028
  6.4.2 Germany Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.4.3 France Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.4.4 U.K. Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.4.5 Italy Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.4.6 Russia Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.4.8 Benelux Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cell-Free DNA (cfDNA) Testing Revenue, 2017-2028
  6.5.2 China Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.5.3 Japan Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.5.4 South Korea Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.5.6 India Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cell-Free DNA (cfDNA) Testing Revenue, 2017-2028
  6.6.2 Brazil Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.6.3 Argentina Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cell-Free DNA (cfDNA) Testing Revenue, 2017-2028
  6.7.2 Turkey Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.7.3 Israel Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028
  6.7.5 UAE Cell-Free DNA (cfDNA) Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Agilent Technology
  7.1.1 Agilent Technology Corporate Summary
  7.1.2 Agilent Technology Business Overview
  7.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.1.4 Agilent Technology Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.1.5 Agilent Technology Key News
7.2 Allenex
  7.2.1 Allenex Corporate Summary
  7.2.2 Allenex Business Overview
  7.2.3 Allenex Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.2.4 Allenex Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.2.5 Allenex Key News
7.3 Biocept
  7.3.1 Biocept Corporate Summary
  7.3.2 Biocept Business Overview
  7.3.3 Biocept Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.3.4 Biocept Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.3.5 Biocept Key News
7.4 Biodesix
  7.4.1 Biodesix Corporate Summary
  7.4.2 Biodesix Business Overview
  7.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.4.4 Biodesix Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.4.5 Biodesix Key News
7.5 CareDx
  7.5.1 CareDx Corporate Summary
  7.5.2 CareDx Business Overview
  7.5.3 CareDx Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.5.4 CareDx Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.5.5 CareDx Key News
7.6 Guardant Health
  7.6.1 Guardant Health Corporate Summary
  7.6.2 Guardant Health Business Overview
  7.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.6.4 Guardant Health Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.6.5 Guardant Health Key News
7.7 Illumania
  7.7.1 Illumania Corporate Summary
  7.7.2 Illumania Business Overview
  7.7.3 Illumania Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.7.4 Illumania Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.7.5 Illumania Key News
7.8 Invited
  7.8.1 Invited Corporate Summary
  7.8.2 Invited Business Overview
  7.8.3 Invited Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.8.4 Invited Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.8.5 Invited Key News
7.9 Natera
  7.9.1 Natera Corporate Summary
  7.9.2 Natera Business Overview
  7.9.3 Natera Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.9.4 Natera Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.9.5 Natera Key News
7.10 Quest Diagnostics
  7.10.1 Quest Diagnostics Corporate Summary
  7.10.2 Quest Diagnostics Business Overview
  7.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.10.4 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.10.5 Quest Diagnostics Key News
7.11 Roche Holdings
  7.11.1 Roche Holdings Corporate Summary
  7.11.2 Roche Holdings Business Overview
  7.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.11.4 Roche Holdings Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.11.5 Roche Holdings Key News
7.12 Sequenom
  7.12.1 Sequenom Corporate Summary
  7.12.2 Sequenom Business Overview
  7.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.12.4 Sequenom Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.12.5 Sequenom Key News
7.13 Trovagene
  7.13.1 Trovagene Corporate Summary
  7.13.2 Trovagene Business Overview
  7.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Major Product Offerings
  7.13.4 Trovagene Cell-Free DNA (cfDNA) Testing Revenue in Global Market (2017-2022)
  7.13.5 Trovagene Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cell-Free DNA (cfDNA) Testing Market Opportunities & Trends in Global Market
Table 2. Cell-Free DNA (cfDNA) Testing Market Drivers in Global Market
Table 3. Cell-Free DNA (cfDNA) Testing Market Restraints in Global Market
Table 4. Key Players of Cell-Free DNA (cfDNA) Testing in Global Market
Table 5. Top Cell-Free DNA (cfDNA) Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cell-Free DNA (cfDNA) Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cell-Free DNA (cfDNA) Testing Product Type
Table 9. List of Global Tier 1 Cell-Free DNA (cfDNA) Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell-Free DNA (cfDNA) Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cell-Free DNA (cfDNA) Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cell-Free DNA (cfDNA) Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cell-Free DNA (cfDNA) Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cell-Free DNA (cfDNA) Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2023-2028
Table 30. Agilent Technology Corporate Summary
Table 31. Agilent Technology Cell-Free DNA (cfDNA) Testing Product Offerings
Table 32. Agilent Technology Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)
Table 33. Allenex Corporate Summary
Table 34. Allenex Cell-Free DNA (cfDNA) Testing Product Offerings
Table 35. Allenex Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)
Table 36. Biocept Corporate Summary
Table 37. Biocept Cell-Free DNA (cfDNA) Testing Product Offerings
Table 38. Biocept Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)
Table 39. Biodesix Corporate Summary
Table 40. Biodesix Cell-Free DNA (cfDNA) Testing Product Offerings
Table 41. Biodesix Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)
Table 42. CareDx Corporate Summary
Table 43. CareDx Cell-Free DNA (cfDNA) Testing Product Offerings
Table 44. CareDx Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)
Table 45. Guardant Health Corporate Summary
Table 46. Guardant Health Cell-Free DNA (cfDNA) Testing Product Offerings
Table 47. Guardant Health Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)
Table 48. Illumania Corporate Summary
Table 49. Illumania Cell-Free DNA (cfDNA) Testing Product Offerings
Table 50. Illumania Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)
Table 51. Invited Corporate Summary
Table 52. Invited Cell-Free DNA (cfDNA) Testing Product Offerings
Table 53. Invited Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)
Table 54. Natera Corporate Summary
Table 55. Natera Cell-Free DNA (cfDNA) Testing Product Offerings
Table 56. Natera Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)
Table 57. Quest Diagnostics Corporate Summary
Table 58. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product Offerings
Table 59. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)
Table 60. Roche Holdings Corporate Summary
Table 61. Roche Holdings Cell-Free DNA (cfDNA) Testing Product Offerings
Table 62. Roche Holdings Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)
Table 63. Sequenom Corporate Summary
Table 64. Sequenom Cell-Free DNA (cfDNA) Testing Product Offerings
Table 65. Sequenom Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)
Table 66. Trovagene Corporate Summary
Table 67. Trovagene Cell-Free DNA (cfDNA) Testing Product Offerings
Table 68. Trovagene Cell-Free DNA (cfDNA) Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cell-Free DNA (cfDNA) Testing Segment by Type in 2021
Figure 2. Cell-Free DNA (cfDNA) Testing Segment by Application in 2021
Figure 3. Global Cell-Free DNA (cfDNA) Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cell-Free DNA (cfDNA) Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cell-Free DNA (cfDNA) Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue in 2021
Figure 8. By Type - Global Cell-Free DNA (cfDNA) Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cell-Free DNA (cfDNA) Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cell-Free DNA (cfDNA) Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cell-Free DNA (cfDNA) Testing Revenue Market Share, 2017-2028
Figure 12. US Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cell-Free DNA (cfDNA) Testing Revenue Market Share, 2017-2028
Figure 16. Germany Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cell-Free DNA (cfDNA) Testing Revenue Market Share, 2017-2028
Figure 24. China Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cell-Free DNA (cfDNA) Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cell-Free DNA (cfDNA) Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cell-Free DNA (cfDNA) Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Agilent Technology Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allenex Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Biocept Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biodesix Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. CareDx Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Guardant Health Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Illumania Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Invited Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Natera Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Roche Holdings Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sequenom Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Trovagene Cell-Free DNA (cfDNA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)